Watch this on-demand programme chaired by Prof Naveed Sattar (School of Cardiovascular and Metabolic Health, Glasgow, UK). Radcliffe Cardiology presents a distinguished panel of experts: Prof Gabriel Steg (University Institute of France, Paris, FR), Prof Lale Tokgozoglu (Hacettepe University, Ankara, TR), and Dr Joshua Stolker (St Louis Hospital, Missouri, US). This roundtable discussion explores the thrombotic risk posed by acute infections, including COVID-19, delving into the emerging data and underlying mechanisms. The panel also identifies patients at increased cardiovascular risk and discusses potential treatment approaches for these patients.
Z4-71980 DoP: February 2025
Learning Objectives
- Identify patients at increased risk for thrombotic events associated with acute infections including COVID 19
- Understand the mechanisms of increased thrombotic risk and the relationship to inflammation that may lead to plaque destabilisation and coagulation
- Understand the challenges posed by emerging studies on COVID-19's thrombotic risk due to factors like vaccination and new variants
- Discuss potential treatment approaches for patients with cardiovascular risk and acute infective episodes
Target Audience
- Healthcare Professionals
More from this programme
Faculty Biographies
Joshua Stolker
Dr Joshua M. Stolker is a distinguished cardiologist based in Saint Louis, Missouri, renowned for his exceptional expertise and compassionate patient care.
With over two decades of experience, Dr Joshua M. Stolker has become a trusted figure in the medical community. He is affiliated with esteemed institutions such as the Harry S. Truman VA Medical Center and Mercy Hospital Washington, where he continues to make significant contributions to cardiovascular care.
Naveed Sattar
Professor of Metabolic Medicine
Prof Naveed Sattar is a distinguished Professor of Metabolic Medicine at the renowned Institute of Cardiovascular and Medical Sciences, University of Glasgow. With over two decades of dedicated research and clinical experience, Prof Naveed Sattar has emerged as a leading figure in the field of metabolic medicine and cardiovascular health.
Prof Naveed Sattar's research delves into the origins, evaluation, and treatment of diabetes, obesity, and cardiovascular conditions. Collaborating with various colleagues over the past two decades, he has authored numerous impactful papers, notably with the Emerging Risk Factor Consortium and diabetes registries in Scotland and Sweden. Prof Naveed Sattar has contributed to several lifestyle-focused trials, such as DIRECT, EUROFIT, and UPBEAT, producing mechanistic insights alongside.
Philippe Gabriel Steg
Interventional Cardiologist
Prof Philippe Gabriel Steg works as an Interventional Cardiologist and is Director of the Coronary Care Unit of Hôpital Bichat, in Paris, France.
Prof Steg’s research interests are in the field of coronary artery disease. He is a former member of the Board of the French Society of Cardiology, an honorary member of the Institut Universitaire de France, and received the silver medal of the European Society of Cardiology in 2011.
Prof Steg led the TAO and EUROMAX trials and is chairing or co-chairing several trials or registries, such as ODYSSEY-CV Outcomes, CLARIFY, THEMIS. Prof Steg has authored more than 650 articles in peer-reviewed international journals. He is a member of the editorial boards for Circulation, Circulation: Cardiovascular Interventions, the European Heart Journal, and the European Heart Journal – Cardiovascular Pharmacotherapy. He is deputy editor for the…
